Sera Prognostics Inc (NAS:SERA)

Q3 2025 Sera Prognostics Inc Earnings Call Transcript

Nov 13, 2025 / 10:00 PM GMT

Release Date Price: $2.95 (-5.45%)

Transcript 10-Q8-K

Key Points

Positve

Sera Prognostics Inc (SERA) is making significant progress in the adoption of its preterm test, with a focus on Medicaid pilot programs, including a live pilot in Nevada.
The company is actively engaging with 10 payers across 13 states, indicating strong commercial momentum and potential for broader adoption.
Sera Prognostics Inc (SERA) has a geographically focused strategy, targeting states with high preterm birth rates and strong alignment with local healthcare leaders.
The company is preparing to publish the full results of its prime study in a peer-reviewed journal, which is expected to bolster its evidence base and support adoption.
Sera Prognostics Inc (SERA) has strengthened its leadership team with key appointments, including a new Chief Medical Officer and head of commercial operations, to drive test adoption and integration.

Negative

Net revenue for the third quarter was only $16,000, a decrease from $29,000 in the same period last year, indicating slow revenue growth.
Total operating expenses increased slightly to $9.0 million, which may impact profitability as the company invests in commercialization efforts.
The path to achieving state Medicaid coverage is lengthy, with an anticipated cycle of 24 months or more, delaying potential revenue realization.
The company is still in the early stages of commercialization, with only one Medicaid pilot program currently live.
Sera Prognostics Inc (SERA) faces challenges in achieving guideline inclusion for its preterm test, which is expected to take 24 to 36 months post-publication.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SERA.OQ - Sera Prognostics Inc
Q3 2025 Sera Prognostics Inc Earnings Call
Nov 13, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Serra Prognostics conference call to review 3rd quarter fiscal year 2025 results. At this time, all participants are in less only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would like to turn the call over to Jennifer Zibuda, Sarah's head of investor relations, for a few introductory comments. Sarah, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon everyone. Welcome to Cerra

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.